Factors Associated with Procedure-related Tumor Seeding in Advanced Stage Lung Cancer Patients with Malignant Pleural Effusions
DOI:
https://doi.org/10.31584/jhsmr.20241053Keywords:
lung cancer, malignant pleural effusion, pleural procedure, track seeding, tumor implantationAbstract
Objective: Pleural procedure-related tumor seeding detected by computed tomography (CT) is common in lung cancer patients with malignant pleural effusion. This study aimed to identify the incidence of tumor seeding and the associated factors among lung cancer patients with malignant pleural effusions.
Material and Methods: This retrospective cohort study was conducted on 146 lung cancer patients with malignant pleural effusions, diagnosed between 2010 and 2017, who underwent at least 1 pleural procedure and had at least 2 series of CT images. The potential factors were categorized into clinical characteristics, pleural characteristics, treatment factors, and pleural procedures. Incidence rate ratios (IRR) were analyzed by Poisson regression to identify factors that were independently associated with tumor seeding.
Results: The incidence of procedure-related tumor seeding was 26%. Significantly increased IRRs of tumor seeding were found in relation to 1 time (IRR 5.653, 95% confidence interval [CI] 2.549 to 12.538) and ≥2 times of conventional intercostal chest drainage (ICD) insertion (IRR 5.837, 95% CI 1.768 to 19.266), 1 time (IRR 8.924, 95% CI 3.181 to 25.033) and ≥2 times of pleural biopsy (IRR 6.485, 95% CI 1.372 to 30.660), adenocarcinoma (IRR 8.329, 95% CI 2.804 to 24.747), and pleural thickening (IRR 12.458, 95% CI 1.360 to 114.152).
Conclusion: Patients who had at least one pleural biopsy or ICD insertion, pleural fluid cytology positive or suspicious for malignancy, adenocarcinoma, or pleural thickening were found to be significantly at risk for tumor seeding.
References
Psallidas I, Kalomenidis I, Porcel JM, Robinson BW, Stathopoulos GT. Malignant pleural effusion: from bench to bedside. Eur Respir Rev 2016;25:189-98.
Agarwal PP, Seely JM, Matzinger FR, MacRae RM, Peterson RA, Maziak DE, et al. Pleural mesothelioma: sensitivity and incidence of needle track seeding after image-guided biopsy versus surgical biopsy. Radiology 2006;241:589-94.
Mitchell MA, Li P, Pease C, Hosseini S, Souza C, Zhang T, et al. Catheter tract metastasis in mesothelioma patients with indwelling pleural catheters: a retrospective cohort study. Respiration 2019;97:428-35.
Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ. Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010;65 (Suppl 2):ii32-40.
Valle LGM, Rocha RD, Mendes GF, Succi JE, de Andrade JR. Tumor seeding along the needle track after percutaneous lung biopsy. J Bras Pneumol 2016;42:71.
Voravud N, Shin DM, Dekmezian RH, Dimery I, Lee JS, Hong WK. Implantation metastasis of carcinoma after percutaneous fine-needle aspiration biopsy. Chest 1992;102:313-5.
Yoshikawa T, Yoshida J, Nishimura M, Yokose T, Nishiwaki Y, Nagai K. Lung cancer implantation in the chest wall following percutaneous fine needle aspiration biopsy. Jpn J Clin Oncol 2000;30:450-2.
Paik HC, Lee DY, Lee HK, Kim SJ, Lee KB. Chest wall implantation of carcinoma after fine needle aspiration biopsy. Yonsei Med J 1994;35:349-54.
Loh LC, Thayaparan T, Yusoff SM, Yunus RKS. Chest wall implantation of lung cancer following chest tube drainage of a pleural effusion. Grand Round 2005;5:10-4.
Sugi K, Nawata K, Ueda K, Kaneda Y, Nawata S, Oga A. et al. Chest wall implantation of lung cancer at the drainage tube site: report of a case. Surg Today 1997;27:666-8.
Janes SM, Rahman NM, Davies RJO, Lee YCG. Catheter-tract metastases associated with chronic indwelling pleural catheters. Chest 2007;131:1232-4.
Stewart BN, Block AJ. Subcutaneous Implantation of Cancer following Thoracentesis. Chest 1974;66:456-7.
Reichner CA, Read CA. Subcutaneous metastatic seeding after removal of a Pleurx catheter. J Bronchol Interv Pulmonol 2006;13:97-8.
Yamaguchi K, Yoshino K, Imafuku K, Tsuboi S, Ohara K. Case of primary pleural angiosarcoma with malignant seeding along the pleural tap tract. J Dermatol 2017;44:e75-6.
Kumar UN, Varkey B. Case report: subcutaneous metastasis. Rare complication of drainage of malignant pleural fluid. Postgrad Med 1976;60:253-5.
Downey RJ, McCormack P, LoCicero J. Dissemination of malignant tumors after video-assisted thoracic surgery: a report of twenty-one cases. The Video-Assisted Thoracic Surgery Study Group. J Thorac Cardiovasc Surg 1996;111:954-60.
Sartorelli KH, Partrick D, Meagher DP. Port-site recurrence after thoracoscopic resection of pulmonary metastasis owing to osteogenic sarcoma. J Pediatr Surg 1996;31:1443-4.
Anraku M, Nakahara R, Matsuguma H, Yokoi K. Port site recurrence after video-assisted thoracoscopic resection of chest wall schwannoma. Interact Cardiovasc Thorac Surg 2003;2:483-5.
Cattapan K, Tanomkiat W, Geater SL, Kiranantawat N. Procedure-related tumour seeding in lung cancer with malignant pleural effusion: Radiological features and outcomes. J Med Imaging Radiat Oncol 2018;62:619–24.
Song YG, Lee MO, Nam Y, Kim TJ, Kim DS, Jang H, et al. Tract seeding in indwelling pleural catheter placement for the drainage of malignant pleural effusions: Incidence and related clinical and imaging factors. Eur J Radiol 2023;166.
Leung AN, Muller NL, Miller RR. CT in differential diagnosis of diffuse pleural disease. AJR Am J Roentgenol 1990;154:487-92.
Hashimoto M, Yuki M, Kitajima K, Fukuda A, Nakamichi T, Nakamura A, et al. Incidence and risk factors of chest wall metastasis at biopsy sites in patients with malignant pleural mesothelioma. Cancers 2022;14:4356.
Shyamala K, Girish H, Murgod S. Risk of tumor cell seeding through biopsy and aspiration cytology. J Int Soc Prev Community Dent 2014;4:5-11.
Samet JM. The epidemiology of lung cancer. Chest 1993;103(1 Suppl):20S-9.
Lewis R, Caccavale R, Sisler G, Bocage J. Does VATS favor seeding of carcinoma of the lung more than a conventional operation? Int Surg 1997;82:127-30.
Reymond MA, Schneider C, Kastl S, Hohenberger W, Kockerling F. The pathogenesis of port-site recurrences. J Gastrointest Surg 1998;2:406–14.
Reymond MA, Wittekind C, Jung A, Hohenberger W, Kirchner T, Köckerling F. The incidence of port-site metastases might be reduced. Surg Endosc 1997;11:902-6.
Hewett PJ, Thomas WM, King G, Eaton M. Intraperitoneal cell movement during abdominal carbon dioxide insufflation and laparoscopy. An in vivo model. Dis Colon Rectum 1996;39:S62-6.
Allardyce RA, Morreau P, Bagshaw PF. Operative factors affecting tumor cell distribution following laparoscopic colectomy in a porcine model. Dis Colon Rectum 1997;40:939-45.
Schneider C, Jung A, Reymond MA, Tannapfel A, Balli J, Franklin ME, et al. Efficacy of surgical measures in preventing port-site recurrences in a porcine model. Surg Endosc 2001;15:121-5.
Lee C, Bayman N, Swindell R, Faivre-Finn C. Prophylactic radiotherapy to intervention sites in mesothelioma: a systematic review and survey of UK practice. Lung Cancer 2009;66:150-6.
Loveland P, Christie M, Hammerschlag G, Irving L, Steinfort D. Diagnostic yield of pleural fluid cytology in malignant effusions: an Australian tertiary centre experience. Intern Med J 2018;48:1318-24.
Hamad F, Souza C, Mitchell M, Amjadi K. Tract metastasis in patients with long-term pleural catheter-computed tomography diagnosis and longitudinal assessment. Eur Radiol 2021;31:7325–31.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
